• MBX Biosciences will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Nov. 10, 2026, in Boston.
• Management will also appear at the UBS Global Biopharma Conference on Nov. 17, 2026, in London.
• A third investor event is scheduled at the Jefferies Global Healthcare Conference on Nov. 18, 2026, in London.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MBX Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610130800PRIMZONEFULLFEED9843979) on October 13, 2026, and is solely responsible for the information contained therein.